The presence of PAX2 in breast tumours has been described many years ago [14,16], but the role of the transcription factor in these tumours remained unknown until recently, when PAX2 was shown to dictate the response of luminal breast cancer cells to tamoxifen [17]. Here, PAX2 is linked to neoplasm.